This game offers such an overwhelming level of character customization that everything else in the genre feels limited by ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...

The Oklahoma Corporation Commission approves PSO’s request to purchase a power plant in Jenks. PSO first asked OCC to buy the Green Country Power Plant from Tokyo-based J-Power back in September. The ...

Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...

TULSA, Okla. — Public Service of Oklahoma is asking for a 15% rate increase that could take effect in July 2026, adding about $25 to the average customer's monthly bill if approved by the Oklahoma ...

KJ Muldoon received a groundbreaking new treatment earlier this year. The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead ...

Scott Pelley, one of the most experienced and awarded journalists today, has been reporting stories for 60 Minutes since 2004. The 2024-25 season is his 21st on the broadcast. Scott has won half of ...

The FDA has issued its stamp of approval to a new, cell-based option to treat Wiskott-Aldrich syndrome (WAS), marking the first therapy of its kind for the rare disease and making Italy’s Fondazione ...

Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike ...

NTRK gene family fusions occur in less than 1% of all solid tumors, but represent one of the most actionable oncogenic alterations across cancer types. Patients harboring these fusions can benefit ...

Entrepreneurs say it’s time to safety-test designer baby technology. A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...

Pillar's research-use-only (RUO) oncoReveal ® Essential MPN, a rapid 3-gene NGS panel designed to quickly streamline the evaluation of myeloproliferative neoplasms (MPN) through the interrogation of ...